Trial Profile
A phase II trial of resolvine ER in patients with moderate stage diabetic retinopathy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs Resolvine (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 20 Oct 2016 New trial record